Drug Type Monoclonal antibody |
Synonyms Anti-CLDN3 monoclonal antibody - Abion, ABN 501, ABN-501 |
Target |
Mechanism CLDN3 inhibitors(claudin 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | KR | 14 Apr 2022 |